C. BEUTNER ET AL.
Open Access IJOHNS
258
Outcome and Predictors of Response,” Gastroenterology,
Vol. 110, No. 5, 1996, pp. 1410-1415.
http://dx.doi.org/10.1053/gast.1996.v110.pm8613045
[7] I. Schneider, W. Thumfart and H. E. Eckel, “Treatment of
Dysfunction of the Cricopharyngeal Muscle with Bot u li n u m
Toxin. Introduction of a New, Non-Invasive Method,”
Annals of Otology, Rhinology, and Laryngology, Vol. 103,
1994, pp. 31-35.
[8] M. B. J. Moermann and B. J. Mieke, “Cricopharyngeal
Botox Injection: Indication and Technique,” Current Opin-
ion in Otolaryngology & Head and Neck Surgery, Vol. 14,
No. 6, 2006, pp. 431-436.
http://dx.doi.org/10.1097/MOO.0b013e328010b85b
[9] S. I. Atkinson and J. Rees, “Botulinum Toxin for Crico-
pharyngeal Dysphagia: Case Reports of CT-Guided In-
jection,” Journal of Otolaryngology, Vol. 26, No. 4, 1997,
pp. 273-276.
[10] V. Annese and G. Bassotti, “Non-Surgical Treatment of
Esophageal Achalasia,” World Journal of Gastroenterol-
ogy, Vol. 12, No. 36, 2006, pp. 5763-5766.
[11] V. Annese, G. Bassotti, G. Coccia, M. Dinelli, V. D’Onofrio,
G. Gatto, et al. and the GISMAD Achalasia Study Group,
“A Multicentre Randomised Study of Intrasphincteric
Botulinum Toxin in Patient s wit h Oesophageal A cha l asia,”
Gut, Vol. 46, No. 5, 2000, pp. 597-600.
http://dx.doi.org/10.1136/gut.46.5.597
[12] M. Storr, P. Born, E. Frimberger, N. Weigert, T. Rösch,
A. Meining, et al., “Treatment of Achalasia: The Short-
Term Response to Botulinum Toxin Injection Seems to
be Independent of Any Kind of Pre-Treatment,” BMC
Gastroenterology, Vol. 2, 2002, p. 19.
http://dx.doi.org/10.1186/1471-230X-2-19
[13] G. Zaninotto, R. Marchese-Ragona, C. Briani, M. Costan-
tini, C. Rizzetto, G. Portale, et al., “The Role of Bo t ul i n um
Toxin Injection and Upper Esopha geal Sphincter Myotomy
in Treating Oropharyngeal Dysphagia,” Journal of Gas-
trointestinal Surgery, Vol. 8, No. 8, 2004, pp. 997-1006.
http://dx.doi.org/10.1016/j.gassur.2004.09.037
[14] C. Cuillere, P. Ducrotté, F. Zerbib, E. H. Metman, D. de
Looze, F. Guillemot, et al., “Achalasia: Outcome of Pa-
tients Treated with Intrasphincteric Injection of Botulinu m
Toxin,” Gut, Vol. 41, No. 1, 1997, pp. 87-92.
http://dx.doi.org/10.1136/gut.41.1.87
[15] V. M. Fishman, H. P. Parkman, T. D. Schiano, C. Hills,
M. A. Dabezies, S. Cohen, et al., “Symptomatic Improve-
ment in Achalasia after Botulinum Toxin Injection of the
Lower Esophageal Sphincter,” American Journal of Gas-
troenterology, Vol. 91, No. 9, 1996, pp. 1724-1730.
[16] J. Kolbasnik, E. W. Wat erfall, B. Fachni e, Y. Chen and G.
Tougas, “Long-Term Efficacy of Botulinum Toxin in Cl as-
sical Achalasia: A Prospective Study,” American Journal
of Gastroenterology, Vol. 94, No. 12, 2004, pp. 3434-
3439.
http://dx.doi.org/10.1111/j.1572-0241.1999.01605.x
[17] V. F. Eckardt, C. Aignherr and G. Bernhard, “Predictors
of Outcome in Patients with Achalasia Treated by Pneu-
matic Dilation,” Gastroenterology, Vol. 103, 1992, pp.
1732-1738.
[18] M. Naumann, W. H. Jost and K. V. Toyka, “Botulinum
Toxin in the Treatment of Neurological Disorders of the
Autonomic Nervous System,” Archives of Neurology, Vol.
56, 1999, pp. 914-916.
http://dx.doi.org/10.1001/archneur.56.8.914
[19] C. F. Torbey, C. Singaram, P. Bass and E. A. Gaumnitz,
“Action of Botulinum Toxin on Gut Smooth Muscle In-
volves Cholinergic and Non-C holinergic Neural Pathway ,”
Gastroenterology, Vol. 112, 1997, p. A840.
[20] A. Blitzer and M. F. Brin, “Use of Botulinum Toxin for
Diagnosis and Management of Cricopharyngeal Ach a l as i a, ”
Otolaryngology—Head and Neck Surgery, Vol. 116, No.
3, 1997, pp. 328-330.
http://dx.doi.org/10.1016/S0194-5998(97)70267-5
[21] G. Y. Shaw and J. P. Searl, “Botulinum Toxin Treatment
for Cricopharyngeal Dysfunction,” Dysphagia, Vol. 16,
No. 3, 2001, pp. 161-167.
http://dx.doi.org/10.1007/s00455-001-0074-8
[22] J. Alberty, M. Oelrich, K. Ludwig, S. Hartmann and W.
Stoll, “Efficacy of Botulinum Toxin A for the Treatment
of Upper Esophageal Sphincter Dysfunction,” Laryngo-
scope, Vol. 110, No. 7, 2000, pp. 1151-1156.
http://dx.doi.org/10.1097/00005537-200007000-00016
[23] M. Moermann, Y. Callier, C. Dick and H. Vermeersch,
“Botulinum Toxin for Dysphagia Due to Cricopharyngeal
Dysfunction,” European Archives of Oto-Rhino-Laryn-
gology, Vol. 259, No. 1, 2002, pp. 1-3.
http://dx.doi.org/10.1007/PL00007520
[24] R. Marchese-Ragona, G. Marioni, D. A. Restivo and A.
Staffieri, “Solving Dysphagia Due to Cricopharyngeal
Muscle Dysfunction with Botulinum Toxin,” European
Archives of Oto-Rhino-Laryngology, Vol. 262, No. 3,
2005, pp. 250-251.
http://dx.doi.org/10.1007/s00405-004-0776-2
[25] F. Mancini, G. Sandrini, A. Moglia, G. Nappi and C.
Pacchetti, “A Randomized, Double-Blind, Dose-Ranging
Study to Evaluate Efficacy and Safety of Three Doses of
Botulinum Toxin Type A (Botox) for the Treatment of
Spastic Foot,” Neurological Sciences, Vol. 26, No. 1, 2005,
pp. 26-31. http://dx.doi.org/10.1007/s10072-005-0378-9
[26] D. Dressler and J. C. Rothwell, “Electromyographic
Quantification of the Paralysing Effect of Botulinum
Toxin in the Sternomastoid Muscle,” European Neurol-
ogy, Vol. 43, No. 1, 2000, pp. 13-16.
http://dx.doi.org/10.1159/000008122
[27] W. E. Waterfall, G. Tougas, B. Fachnie and U. Chauhan,
“Clinical and Manometric Response to Botulinum Toxin
(Botox) Used as Primary Treatment for Achalasia,” Gas-
troenterology, Vol. 108, 1995, p. A225.
[28] R. Mac Ever, M. Liptay and Y. Johnson, “A Case of Me-
diastinitis Following Botulinum Toxin Type A Treatment
for Achalasia,” Nature Clinical Practice Gastroenterol-
ogy & Hepatology, Vol. 4, No. 10, 2007, pp. 579-582.
http://dx.doi.org/10.1038/ncpgasthep0951
[29] L. Dughera, E. Battaglia, D. Maggio, P. Cassolino, P. R.
Mioli, A. Morelli, G. Emanuelli, et al., “Botulinum Toxin
Treatment of Oesophageal Achalasia in the Old Old and
Oldest Old: A 1-Year Follow-Up Study,” Drugs Aging,
2005, Vol. 22, No. 9, pp. 779-783.
http://dx.doi.org/10.2165/00002512-200522090-00006